Skip to main content
ABT
NYSE Life Sciences

FDA Approves Abbott's SimpleScreen CRC, Triggering $100M Milestone

Tom Rudovsky · Reported by Wiseek News
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$106
Mkt Cap
$182.902B
52W Low
$81.97
52W High
$137.49
52W Position info
29% above low
Off High info
23% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

ABT sits 29% above its 52-week low of $81.97.

Summary

Abbott won FDA approval for SimpleScreen CRC, a colorectal cancer screening test for average-risk adults 45+. The approval aligns with Medicare and ACS guidelines, likely expanding clinical access. It also triggers a $100M milestone payment to Freenome under their contract. This follows Abbott's Q2 beat and raised guidance, adding a new growth driver in diagnostics. The approval strengthens Abbott's position in cancer screening, a market with significant potential.

At the time of this announcement, ABT was trading at $106.00 on NYSE in the Life Sciences sector, with a market capitalization of approximately $182.9B. The 52-week trading range was $81.97 to $137.49. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

ABT - Latest Insights

ABT
Nov 04, 2026, 4:13 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $115.48
Real-time Price: $103.00 info
Change: -$12.48 (-11%) info
Market Cap: $178.39B info
ABT
Oct 21, 2026, 8:53 AM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $98.21
Real-time Price: $103.00 info
Change: +$4.79 (+5%) info
Market Cap: $178.39B info
ABT
Oct 21, 2026, 7:36 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $99.52
Real-time Price: $103.00 info
Change: +$3.48 (+3%) info
Market Cap: $178.39B info
ABT
Oct 21, 2026, 7:32 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $100.55
Real-time Price: $103.00 info
Change: +$2.45 (+2%) info
Market Cap: $178.39B info
ABT
Oct 21, 2026, 7:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $100.52
Real-time Price: $103.00 info
Change: +$2.48 (+2%) info
Market Cap: $178.39B info